Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 606
Recruiting: 317
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–50 of 113 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05370807	A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma(RegoMel)	active not recruiting	Phase 2	48	Universitair Ziekenhuis BrusselOTHER	1	Sep 30, 2026	clinicaltrials
NCT06305247	A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours	active not recruiting	Phase 1 / Phase 2	36	IpsenINDUSTRY	3	Sep 30, 2026	clinicaltrials